The indications covered in the study such as primary immunodeficiency (PID), Guillain-Barr syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis; multifocal motor neuropathy
(MMN) and idiopathic thrombocytopenic purpura (ITP) have very low prevalence and incidence rates.
These include PID, CIDP, multifocal motor neuropathy, myasthenia gravis, chronic lymphocytic leukemia, guillain-barre syndrome and idiopathic thrombocytopenic purpura.
Market characterization of the immunoglobulins (PID, CIDP, multifocal motor neuropathy, myasthenia gravis, chronic lymphocytic leukemia, guillain-barre syndrome and idiopathic thrombocytopenic purpura) market, including market size, revenue analysis by the top seven geographies, annual cost of therapy, and epidemiology.
NYSE:BAX) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for extension of the therapeutic indications of KIOVIG to include a new indication for multifocal motor neuropathy
(MMN), a severe, debilitating disorder requiring lifelong treatment.
Over the last 12 months, Baxter has initiated 14 Phase III clinical trials, and is advancing numerous earlier stage clinical trials of therapies that have the potential to profoundly impact the treatment and delivery of care for chronic diseases like Alzheimer's, kidney failure, cardiovascular, diabetes, thrombotic thrombocytopenic purpura, multifocal motor neuropathy
, as well as public health threats like pandemic and seasonal influenza.